Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa adaptive crossover trial of prolonged-release ketamine tablets for chronic neuropathic pain
2014-004535-40Phase 2Completed
- Sponsor
- Develco Pharma
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of ketamine in Neuralgia (3 arms), sponsored by Develco Pharma. Started Feb 2015; status: completed.
02
Drugs
ketamine
03
Conditions
Neuralgia
Beyond the preview
Go deeper on 2014-004535-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004535-40.